EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Delayed Nyse  -  05/19 04:00:02 pm EDT
94.37 USD   +1.03%
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
05/17Citigroup Adjusts Price Target on Edwards Lifesciences to $115 From $134, Reiterates Buy Rating
MT
05/16Edwards announces key events for europcr 2022
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Evercore ISI Adjusts Edwards Lifesciences PT to $130 From $128, Outperform Rating Kept

01/03/2022 | 12:21pm EDT


© MT Newswires 2022
All news about EDWARDS LIFESCIENCES CORPORATION
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
05/17Citigroup Adjusts Price Target on Edwards Lifesciences to $115 From $134, Reiterates Bu..
MT
05/16Edwards announces key events for europcr 2022
PR
05/11INSIDER SELL : Edwards Lifesciences
MT
05/04EDWARDS LIFESCIENCES CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
04/29INSIDER SELL : Edwards Lifesciences
MT
04/28EDWARDS LIFESCIENCES CORP Management's Discussion and Analysis of Financial Condition ..
AQ
04/28TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 5, 2021.
CI
04/28TRANCHE UPDATE ON EDWARDS LIFESCIENC : EW)'s Equity Buyback Plan announced on May 8, 2019.
CI
04/27Canaccord Genuity Adjusts Edwards Lifesciences' Price Target to $137 from $152, Keeps B..
MT
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2022 5 734 M - -
Net income 2022 1 558 M - -
Net cash 2022 1 316 M - -
P/E ratio 2022 38,2x
Yield 2022 -
Capitalization 58 675 M 58 675 M -
EV / Sales 2022 10,0x
EV / Sales 2023 8,77x
Nbr of Employees 15 700
Free-Float 96,5%
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 94,37 $
Average target price 125,90 $
Spread / Average Target 33,4%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Kieran Thomas Gallahue Independent Director
Sector and Competitors
1st jan.Capi. (M$)
EDWARDS LIFESCIENCES CORPORATION-27.16%58 675
THERMO FISHER SCIENTIFIC-18.74%212 239
DANAHER CORPORATION-24.22%174 392
INTUITIVE SURGICAL, INC.-39.29%77 301
SIEMENS HEALTHINEERS AG-17.17%65 558
BOSTON SCIENTIFIC CORPORATION-7.04%57 512